Digital Health Startups Lack Clinical Credibility, Half Not Reliable

Digital Health Startups Lack Clinical Credibility, Half Not Reliable
This illustration photo taken in Los Angeles on April 6, 2021 shows a person looking at the app for the New York State Excelsior Pass, which provides digital proof of a COVID-19 vaccination, in front of a screen showing the New York skyline. Chris Delmas/AFP via Getty Images
Marina Zhang
Updated:
0:00

A study on American-based digital health start-ups has found that nearly half—44 percent—of digital health startups lack credibility clinically, with a general lack of robustness in clinical findings.

“Many venture-backed startups in digital health have limited clinical robustness (reliability),” the authors wrote in the study.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health writer for The Epoch Times, based in New York. She mainly covers stories on COVID-19 and the healthcare system and has a bachelors in biomedicine from The University of Melbourne. Contact her at [email protected].
Related Topics